Abstract
Objective: A population-based case–control study was conducted to examine the hypothesis that active and passive tobacco smoking were associated with the risk of epithelial ovarian cancer. Methods: In-person interviews were obtained from 558 women with epithelial ovarian cancer (431 invasive, 127 borderline) and 607 population controls regarding active lifetime tobacco smoking, environmental tobacco smoke exposure in utero and during childhood, and other factors that may be related to the development of ovarian cancer. Results: No significant associations of ever or former tobacco smoking with the risk of invasive or borderline ovarian cancer were found, although long-term ex-smokers of 20 years or more were at significantly reduced risk of invasive cancer. Significant, positive dose–response relations of the number of cigarettes smoked per day and pack-years with the odds ratios for borderline cancer were evident. No association of active tobacco smoking with risk was found by histologic subtype of invasive ovarian cancer. Smokers were at significantly increased risk for borderline serous cystadenoma (OR: 1.91; 95% confidence intervals, CI: 1.09–3.34), but not for borderline mucinous cystadenoma. When we limited the analyses to current smokers, age-started smoking was significantly inversely related to the risk of invasive, but not borderline ovarian cancer. We found no association of gestational or childhood environmental tobacco smoke exposure with the risk of invasive or borderline ovarian cancer among never smokers. Conclusions: These findings do not support an association of active tobacco smoking with the risk of invasive ovarian cancer. An increased risk of borderline serous cystadenoma among smokers must be viewed with caution.
Similar content being viewed by others
References
Zenzes MT (2000) Smoking and reproduction: gene damage to human gametes and embryos. Hum Reprod Update 6: 122-131.
Ness RB, Cramer DW, Goodman MT, et al. (2002) Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 155: 217-224.
Hecht SS (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3: 461-469.
Zenzes MT, Reed TE, Casper RF (1997) Effects ofcigarette smoking and age on the maturation ofhuman oocytes. Hum Reprod 12: 1736-1741.
Modugno F, Ness RB, Cottreau C (2002) Cigarette smoking and the risk ofmucinous and nonmucinous epithelial ovarian cancer. Epidemiology 13: 467-471.
Green A, Purdie D, Bain C, Siskind V, Webb PM (2001) Cigarette smoking and risk ofepithelial ovarian cancer (Australia). Cancer Causes Control 12: 713-719.
Marchbanks PA, Wilson H, Bastos E, Cramer DW, Schildkraut JM, Peterson HB (2000) Cigarette smoking and epithelial ovarian cancer by histologic type. Obstet Gynecol 95: 255-260.
Doll R, Gray R, Hafner B, Peto R (1980) Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J 280: 967-971.
Whittemore AS, Wu ML, Paffenbarger RSJr, et al. (1988) Personal and environmental characteristics related to epithelial ovarian cancer: II. Exposures to talcum powder, tobacco, alcohol, and coffee. Am J Epidemiol 128: 1228-1240.
Polychronopoulou A, Tzonou A, Hsieh CC, et al. (1993) Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer. Int J Cancer 55: 402-407.
Franks AL, Lee NC, Kendrick JS, Rubin GL, Layde PM (1987) Cigarette smoking and the risk ofepithelial ovarian cancer. Am J Epidemiol 126: 112-117.
Stockwell HG, Lyman GH (1987) Cigarette smoking and the risk off emale reproductive cancer. Am J Obstet Gynecol 157: 35-40.
Engeland A, Andersen A, Haldorsen T, Tretli S (1996) Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26,000 Norwegian men and women. Cancer Causes Control 7: 497-506.
Kuper H, Titus-Ernstoff L, Harlow BL, Cramer DW (2000) Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer 88: 313-318.
Hartge P, Schiffman MH, Hoover R, McGowan L, Lesher L, Norris HJ (1989) A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol 161: 10-16.
Smith EM, Sowers MF, Burns TL (1984) Effects ofsmoking on the development off emale reproductive cancers. J Natl Cancer Inst 73: 371-376.
Tzonou A, Day NE, Trichopoulos D, et al. (1984) The epidemiology of ovarian cancer in Greece: a case-control study. Eur J Cancer Clin Oncol 20: 1045-1052.
Baron JA, Byers T, Greenberg ER, Cummings KM, Swanson M (1986) Cigarette smoking in women with cancers ofthe breast and reproductive organs. J Natl Cancer Inst 77: 677-680.
Nandakumar A, Anantha N, Dhar M, et al. (1995) A case-control investigation on cancer of the ovary in Bangalore, India. Int J Cancer 63: 361-365.
Mori M, Harabuchi I, Miyake H, Casagrande JT, Henderson BE, Ross RK (1988) Reproductive, genetic, and dietary risk factors for ovarian cancer. Am J Epidemiol 128: 771-777.
Byers T, Marshall J, Graham S, Mettlin C, Swanson M (1983) A case-control study of dietary and nondietary factors in ovarian cancer. J Natl Cancer Inst 71: 681-686.
Scully RE, Sobin LH (1999) Histological Typing of Ovarian Tumours. 2nd edn. New York: Springer.
Jauniaux E, Gulbis B, Acharya G, Thiry P, Rodeck C (1999) Maternal tobacco exposure and cotinine levels in fetal fluids in the first halfofpregnancy. Obstet Gynecol 93: 25-29.
Becker AB, Manfreda J, Ferguson AC, Dimich-Ward H, Watson WT, Chan-Yeung M (1999) Breast-feeding and environmental tobacco smoke exposure. Arch Pediatr Adolesc Med 153: 689-691.
Sorahan T, McKinney PA, Mann JR, et al. (2001) Childhood cancer and parental use oftobacco: findings from the interregional epidemiological study ofchildhood cancer (IRESCC). Br J Cancer 84: 141-146.
Goodman MT, Wu AH, Tung KH, et al. (2002) Association of dairy products, lactose, and calcium with the risk ofovarian cancer. Am J Epidemiol 156: 148-157.
Ries LAG, Eisner MP, Kosary CL, et al., eds. (2000) SEER Cancer Statistics Review, 1973-1997. Bathesda, MD: National Cancer Institute, NIH Pub no. 00-2789.
Oyama N, Johnson DB (1986) Hawaii Health Surveillance Program Survey Methods and Procedures. (Research &; Statistics report no. 54). Honolulu: Hawaii State Department of Health, Research and Statistics Office.
Pike MC, Peters RK, Cozen W, et al. (1997) Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst 89: 1110-1116.
Breslow NE, Day NE (1980) Statistical Methods in Cancer Research. The Analysis of Case-Control Studies. Vol. I, Lyon: IARC, (IARC scientific publication no. 32).
Scully RE (2000) Influence of origin of ovarian cancer on efficacy of screening. Lancet 355: 1028-1029.
Crayford TJ, Campbell S, Bourne TH, Rawson HJ, Collins WP (2000) Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening. Lancet 355: 1060-1063.
Hull MG, North K, Taylor H, Farrow A, Ford WC (2000) Delayed conception and active and passive smoking: The Avon Longitudinal Study of Pregnancy and Childhood Study Team. Fertil Steril 74: 725-733.
Miller BA, Kolonel LN, Bernstein L, et al., eds. (1996) Racial/Ethnic Patterns of Cancer in the United States 1988-1992, Bethesda, MD: National Cancer Institute. NIH Pub. no. 96-4104.
Goodman MT, Howe HL, Tung K-H, et al. (2003) Incidence of ovarian cancer by race and ethnicity in the United States, 1992-1997. Cancer 97: 2676-2685.
Kolonel LN, Henderson BE, Hankin JH, et al. (2000) A multiethnic cohort study in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151: 346-357.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goodman, M.T., Tung, KH. Active and passive tobacco smoking and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control 14, 569–577 (2003). https://doi.org/10.1023/A:1024828309874
Issue Date:
DOI: https://doi.org/10.1023/A:1024828309874